• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2011

View Archived Issues

Phase I data presented on MLN-9708 in multiple myeloma

Read More

Plerixafor is beneficial in patients with myelokathexis

Read More

PNB-01 is superior to citalopram in phase II trial in major depressive disorder

Read More

New inhibitors claimed of mitochondrial cytochrome P450 11B1 and 11B2

Read More

Novartis researchers synthesize new neprilysin inhibitors

Read More

Palatin Technologies discloses novel melanocortin MC1 receptor agonists

Read More

New NADPH oxidase 1, dual oxidase 2 and NADPH oxidase 3 inhibitors claimed

Read More

AstraZeneca claims new antagonists of P2X3 receptor and/or P2X2/3 heterodimer

Read More

Merck & Co. patents new GPR119 receptor agonists

Read More

MK-0916 reduces HbA1c and body weight in phase II trial in diabetes/metabolic syndrome

Read More

IBC Generium licenses rights in Russia to Affitech AT-001 antibody

Read More

FDA approves new tamper-resistant immediate-release oxycodone product Oxecta

Read More

EMA committee accepts for review PROLOR's PIP for long-acting human growth hormone

Read More

Pfizer discloses phase I data on PF-03084014 and PF-04554878 in solid tumors

Read More

MAb hu3S193 stabilizes disease in phase II trial in ovarian, peritoneal and fallopian tube cancer

Read More

Lead compound selected in Concert Pharmaceuticals/GSK HIV-PI collaboration

Read More

FDA removes clinical hold on SNS01-T IND in multiple myeloma

Read More

Concert Pharmaceuticals advances new drug candidates in kidney disease and spasticity

Read More

AVI BioPharma starts phase I trial of flu therapy AVI-7100

Read More

Cebix advances C peptide replacement therapy for chronic complications of diabetes

Read More

Topline phase III data show Lyrica efficaciously reduces neuropathic pain after spinal cord injury

Read More

Bristol-Myers Squibb to make milestone payment to Alder Biopharmaceuticals

Read More

Once-weekly exenatide approved in E.U. for type 2 diabetes

Read More

Jubilant and Endo Pharmaceuticals achieve third milestone in joint oncology program

Read More

Phase III LCP-Tacro trial in stable kidney transplant recipients meets primary endpoints

Read More

Lipid Therapeutics' phase IIb trial of LT-02 in ulcerative colitis meets primary endpoint

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 13, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe